RMC No. 4-2019: Publishes the full text of the letter from the Food and Drug Administration containing the “List of VAT-Exempt Diabetes, High-Cholesterol and Hypertension Drugs” pursuant to Joint Administrative Order No. 2-2018

Files
Download this file

Summary

RMC No. 4-2019 publishes the full text of the Food and Drug Administration letter containing the List of VAT-Exempt Diabetes, High-Cholesterol and Hypertension Drugs, issued under Joint Administrative Order No. 2-2018.

Key points

  1. Legal basis. The List is provided under RA No. 8424, as amended by RA No. 10963 (TRAIN Law).

Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.

Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.